Skip to main content

Long-Term Follow-Up and Education Regarding Daily Life Activities, School Life, and Guidelines After Acute KD

  • Chapter
  • First Online:
Kawasaki Disease
  • 1284 Accesses

Abstract

Almost all patients with Kawasaki disease take aspirin for 2–3 months after disease onset. During and after such treatment, patients without coronary artery lesions (CAL) are not restricted with respect to sports, vaccination, or normal daily life activities. Management of daily life activities of patients with CAL depends on individual risk of cardiac events, as determined by appropriate assessment techniques. If the patient requires anticoagulant and/or antiplatelet treatment, external injuries should be avoided and participation in contact sports restricted. When warfarin is used, the dose needs to be carefully monitored by blood testing, and the patient should be informed about foods that increase vitamin K levels. Angiograms obtained by computed tomography or magnetic resonance are beginning to supplant catheter angiograms in the morphological evaluation of CAL; however, these modalities have advantages and disadvantages. Echocardiography and scintigraphy with pharmacological or exercise stress testing is useful in functional studies. However, an experienced examiner must be available to conduct and evaluate the results of such tests. As patients age, they must be made aware of the possibility of cardiac sequelae and the need for transition to an adult cardiologist.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Yamada K, Fukumoto T, Shinkai A, Shirahata A, Meguro T. The platelet functions in acute febrile mucocutaneous lymph node syndrome and a trial of prevention for thrombosis by antiplatelet agent. Nihon Ketsueki Gakkai Zasshi. 1978;41(4):791–802. PMID:716791.

    CAS  PubMed  Google Scholar 

  2. Joint Working Group JCS. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J. 2014;78(10):2521–62. http://dx.doi.org/10.1253/circj.CJ-66-0096 PMID:25241888.

    Article  Google Scholar 

  3. Sonobe T. Practice of immunization: High-dose gamma-globulin therapy and immunization. Shoni naika. 1994;26:1929–33 (in Japanese).

    Google Scholar 

  4. Miura M, Katada Y, Ishihara J. Time interval of measles vaccination in patients with Kawasaki disease treated with additional intravenous immune globulin. Eur J Pediatr. 2004;163(1):25–9. http://dx.doi.org/10.1007/s00431-003-1335-3 PMID:14624356.

    Article  CAS  PubMed  Google Scholar 

  5. Mason W, Jordan S, Sakai R, Takahashi M. Lack of effect of gamma-globulin infusion on circulating immune complexes in patients with Kawasaki syndrome. Pediatr Infect Dis J. 1988;7(2):94–9. http://dx.doi.org/10.1097/00006454-198802000-00006 PMID:2449651.

    Article  CAS  PubMed  Google Scholar 

  6. Suda K, Kudo Y, Higaki T, Nomura Y, Miura M, Matsumura M, et al. Multicenter and retrospective case study of warfarin and aspirin combination therapy in patients with giant coronary aneurysms caused by Kawasaki disease. Circ J. 2009;73(7):1319–23. http://dx.doi.org/10.1253/circj.CJ-08-0931 PMID:19436123.

    Article  CAS  PubMed  Google Scholar 

  7. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, American Academy of Pediatrics, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004;110(17):2747–71. http://dx.doi.org/10.1161/01.CIR.0000145143.19711.78 PMID:15505111.

    Article  PubMed  Google Scholar 

  8. Selamet Tierney ES, Gal D, Gauvreau K, Baker AL, Trevey S, O’Neill SR, et al. Vascular health in Kawasaki disease. J Am Coll Cardiol. 2013;62(12):1114–21. http://dx.doi.org/10.1016/j.jacc.2013.04.090 PMID:23835006.

    Article  PubMed  Google Scholar 

  9. Noto N, Okada T, Yamasuge M, Taniguchi K, Karasawa K, Ayusawa M, et al. Noninvasive assessment of the early progression of atherosclerosis in adolescents with Kawasaki disease and coronary artery lesions. Pediatrics. 2001;107(5):1095–9. http://dx.doi.org/10.1542/peds.107.5.1095 PMID:11331692.

    Article  CAS  PubMed  Google Scholar 

  10. Cheung YF, Yung TC, Tam SC, Ho MH, Chau AK. Novel and traditional cardiovascular risk factors in children after Kawasaki disease: implications for premature atherosclerosis. J Am Coll Cardiol. 2004;43(1):120–4. http://dx.doi.org/10.1016/j.jacc.2003.08.030 PMID:14715193.

    Article  PubMed  Google Scholar 

  11. Mitani Y, Okuda Y, Shimpo H, Uchida F, Hamanaka K, Aoki K, et al. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease. Circulation. 1997;96(2):454–61. PMID:9244212.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mamoru Ayusawa .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Japan

About this chapter

Cite this chapter

Ayusawa, M. (2017). Long-Term Follow-Up and Education Regarding Daily Life Activities, School Life, and Guidelines After Acute KD. In: Saji, B., Newburger, J., Burns, J., Takahashi, M. (eds) Kawasaki Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-56039-5_33

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-56039-5_33

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-56037-1

  • Online ISBN: 978-4-431-56039-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics